S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 12,301 to 12,320 of 144,521

Issue Date	Title / Author(s) / Citation	File
2017-06	BreathPrint: Breathing acoustics-based user authentication Chauhan, Jagmohan; Hu, Yining; Seneviratne, Suranga; Misra, Archan; Seneviratne, Aruna; Lee, Youngki MobiSys 2017 - Proceedings of the 15th Annual International Conference on Mobile Systems, Applications, and Services, pp.278-291	DOI
1992	Brecht nach der Wiedervereinigung Deutschlands- anhand des stücks "Die Haßnahme" Song, Dong-Zun 독일학연구, Vol.1, pp. 21-37	view file
2022-01	Breech Presentation in Twins as a Risk Factor for Developmental Dysplasia of the Hip Oh, Eun Ji; Min, Jae Jung; Kwon, Soon-Sun; Kim, Seong Been; Choi, Chang Won; Jung, Young Hwa; Oh, Kyung Joon; Park, Jee Yoon; Park, Moon Seok Journal of Pediatric Orthopaedics, Vol.42 No.1, pp.E55-E58	DOI
2016-10	Breeding of Sweet Shinhong pepper by Marker-assisted backcrossing (MABC) Jang, Siyoung; Han, Koeun; Jeong, Hyeon-Seok; Kwon, Jin-Kyung; Kang, Byoung-Cheorl 원예과학기술지 Vol. 34 Suppl. 2, pp. 127-128	view file
2004	(+)-Brefeldin A 및 bacillariolide Ⅲ의 입체 선택적인 전합성 서승용	link
2019-03	Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation Hong, Sujeong; Hwang, Inhwa; Gim, Eunji; Yang, Jungmin; Park, Sangjun; Yoon, Sung-Hyun; Lee, Won-Woo; Yu, Je-Wook FASEB Journal, Vol.33 No.3, pp.4547-4558	DOI
2000	(+)-Brefeldin A의 전합성에 관한 연구 서승용	link
1995	Brevibcterium ketoglutamicum arginine 營養要求株를 利用한 오르니틴의 生産 최대건	link
2021-02	Brexit and the Judicial Cooperation in Criminal Matters of the EU 조규현	view file link
2001	Brian Friel의 극 연구 : 진실과 허구의 관계에 대한 인식 박진아	link
2018-08	Bridge Damage Factor Recognition from Inspection Reports Using Active Recurrent Neural Network 정세환	view file
2019-08	Bridge Damage Identification and Its Severity Estimation Using Artificial Intelligence 임소람	view file link
2019-06	Bridge Damage Prediction Using Deep Neural Network Lim, Soram; Chi, Seokho COMPUTING IN CIVIL ENGINEERING 2019: SMART CITIES, SUSTAINABILITY, AND RESILIENCE, pp.219-225	DOI
2015-02	Bridging the Gender Gap on Economic Participation: A comparative study of gender policies in Japan and Sweden 고쎄마린	view file
2022-08	Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced ALK-Positive NSCLC Kim, Dong-Wan; Gadgeel, Shirish; Gettinger, Scott N.; Riely, Gregory J.; Oxnard, Geoffrey R.; Mekhail, Tarek; Schmid, Peter; Dowlati, Afshin; Heist, Rebecca S.; Wozniak, Antoinette J.; Singh, Jatinder; Cha, Edward; Spahn, Jessica; Ou, Sai-Hong Ignatius JTO Clinical and Research Reports, Vol.3 No.8, p. 100367	DOI
2008-05	Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment Lee, Jun-Young; Cho, Seong-Jin; Na, Duk L; Kim, Shin-Kyum; Youn, Jung-Hae; Kwon, Miseon; Lee, Jae-Hong J Geriatr Psychiatry Neurol. 2008 ;21(2):104-10.	link
2021-09	Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK plus non-small cell lung cancer (NSCLC): Final results of the Phase 1/2 and Phase 2 (ALTA) trials Huber, R.; Gettinger, S.; Kim, D. -W; Bazhenova, L.; Hansen, K.; Tiseo, M.; Langer, C.; Paz-Ares Rodriguez, L.; West, H.; Reckamp, K.; Weiss, G.; Smit, E.; Hochmair, M.; Kim, S. -W; Ahn, M. -J; Kim, E.; Groen, H.; Pye, J.; Vranceanu, F.; Camidge, D. R. Oncology Research and Treatment, Vol.44, pp.4-5
2020-03	Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial Huber, Rudolf M.; Hansen, Karin H.; Paz-Ares Rodriguez, Luis; West, Howard L.; Reckamp, Karen L.; Leighl, Natasha B.; Tiseo, Marcello; Smit, Egbert F.; Kim, Dong-Wan; Gettinger, Scott N.; Hochmair, Maximilian J.; Kim, Sang-We; Langer, Corey J.; Ahn, Myung-Ju; Kim, Edward S.; Kerstein, David; Groen, Harry J. M.; Camidge, D. Ross Journal of Thoracic Oncology, Vol.15 No.3, pp.404-415	DOI
2017-08	Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial Kim, Dong-Wan; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen L.; Hansen, Karin Holmskov; Kim, Sang-We; Huber, Rudolf M.; West, Howard L.; Groen, Harry J. M.; Hochmair, Maximilian J.; Leighl, Natasha B.; Gettinger, Scott N.; Langer, Corey J.; Rodriguez, Luis G. Paz-Ares; Smit, Egbert F.; Kim, Edward S.; Reichmann, William; Haluska, Frank G.; Kerstein, David; Camidge, D. Ross Journal of Clinical Oncology, Vol.35 No.22, pp.2490-2498	DOI
2023-12	Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial Yang, James Chih-Hsin; Liu, Geoffrey; Lu, Shun; He, Jianxing; Burotto, Mauricio; Ahn, Myung-Ju; Kim, Dong-Wan; Liu, XiaoQing; Zhao, Yanqiu; Vincent, Sylvie; Yin, Jiani; Ma, Xin; Lin, Huamao M.; Popat, Sanjay Journal of Thoracic Oncology, Vol.18 No.12, pp.1743-1755	DOI

1 615 616 617 618 619 620 621 7227